MedPath
NMPA Approval

Cefprozil for Suspension

国药准字H20254445

June 3, 2025

Drug Information

头孢丙烯干混悬剂

混悬剂

1.25g(按C₁₈H₁₉N₃O₅S计)

化学药品

June 3, 2025

Company Information

Applicant Company

广东省江门市龙溪路117号

Manufacturing Company

广东省江门市龙溪路117号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢丙烯干混悬剂 - NMPA 批准文号 | MedPath